Jones, D. T. W., Witt, O., & Pfister, S. (2018). BRAF V600E status alone is not sufficient as a prognostic biomarker in pediatric low-grade glioma. Journal of clinical oncology, 36(1), . https://doi.org/10.1200/JCO.2017.75.8987
Chicago Style (17th ed.) CitationJones, David T. W., Olaf Witt, and Stefan Pfister. "BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-grade Glioma." Journal of Clinical Oncology 36, no. 1 (2018). https://doi.org/10.1200/JCO.2017.75.8987.
MLA (9th ed.) CitationJones, David T. W., et al. "BRAF V600E Status Alone Is Not Sufficient as a Prognostic Biomarker in Pediatric Low-grade Glioma." Journal of Clinical Oncology, vol. 36, no. 1, 2018, https://doi.org/10.1200/JCO.2017.75.8987.
Warning: These citations may not always be 100% accurate.